Literature DB >> 21372463

Adjunctive effects of cyclosporine and macrolide in rapidly progressive cryptogenic organizing pneumonia with no prompt response to steroid.

Jaehee Lee1, Seung Ick Cha, Tae In Park, Jae Yong Park, Tae Hoon Jung, Chang Ho Kim.   

Abstract

Cryptogenic organizing pneumonia (COP) generally responds well to corticosteroids with a favorable outcome. However, it can rapidly worsen and lead to respiratory failure that is refractory to corticosteroids. Adjunctive drugs have been used in refractory cases with various outcomes, but treatment experience is still lacking. We present a case of rapidly progressive COP accompanying air leak syndrome, which showed no prompt response to corticosteroids alone but gradual improvement with the addition of cyclosporine and macrolide. This case report supports the existing literature suggesting that an early therapeutic trial of this drug combination might be considered in COP patients whose condition worsens despite corticosteroid administration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21372463     DOI: 10.2169/internalmedicine.50.4237

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  11 in total

1.  Intravenous immune globulins (IVIg) treatment for organizing pneumonia in a selective IgG immune deficiency state.

Authors:  Itai Gueta; Yehuda Shoenfeld; Hedi Orbach
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Seven patients with cryptogenic organizing pneumonia succesfully treated with clarithromycin.

Authors:  Fatma Ciftci; Özlem Özdemir Kumbasar
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  Organizing pneumonia revisited: insights and uncertainties from a series of 67 patients.

Authors:  A L Vieira; A Vale; N Melo; P Caetano Mota; J M Jesus; R Cunha; S Guimarães; C Souto Moura; A Morais
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 4.  Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.

Authors:  P Zarogoulidis; N Papanas; I Kioumis; E Chatzaki; E Maltezos; K Zarogoulidis
Journal:  Eur J Clin Pharmacol       Date:  2011-11-22       Impact factor: 2.953

5.  Secondary organizing pneumonia following occupational acute nitrogen oxide poisoning: a case report.

Authors:  Shuang Ma; Baotian Kan; Xiangdong Jian; Chenglin Li; Yingying Zheng; Cece Sun; Yiming Tao; Siqi Cui; Tianzi Jian
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

6.  Macrolide therapy in cryptogenic organizing pneumonia: A case report and literature review.

Authors:  Qun-Li Ding; Dan Lv; Bi-Jiong Wang; Qiao-Li Zhang; Yi-Ming Yu; Shi-Fang Sun; Zhong-Bo Chen; Hong-Ying Ma; Zai-Chun Deng
Journal:  Exp Ther Med       Date:  2015-01-15       Impact factor: 2.447

7.  Complete resolution of steroid-resistant organizing pneumonia associated with myelodysplastic syndrome following allogeneic hematopoietic cell transplantation.

Authors:  Takeru Asano; Nobuharu Fujii; Daigo Niiya; Hisakazu Nishimori; Keiko Fujii; Ken-Ichi Matsuoka; Koichi Ichimura; Toshihisa Hamada; Eisei Kondo; Yoshinobu Maeda; Yasushi Tanimoto; Katsuji Shinagawa; Mitsune Tanimoto
Journal:  Springerplus       Date:  2014-01-02

8.  A Cryptogenic Case of Fulminant Fibrosing Organizing Pneumonia.

Authors:  Takehiko Kobayashi; Masanori Kitaichi; Kazunobu Tachibana; Yutaro Kishimoto; Yasushi Inoue; Tomoko Kagawa; Toshiya Maekura; Chikatoshi Sugimoto; Toru Arai; Masanori Akira; Yoshikazu Inoue
Journal:  Intern Med       Date:  2017-05-15       Impact factor: 1.271

9.  Different Responses to Clarithromycin in Patients with Cryptogenic Organizing Pneumonia.

Authors:  Ji Hyun Oh; Dong Jun Oh; So-My Koo; Yang Ki Kim; Ki Up Kim; Hyun Jo Kim; Dong Won Kim; Soo-Taek Uh
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-10-01

10.  Cryptogenic organizing pneumonia masquerading as lung carcinoma: A case report and review of the literature.

Authors:  Ji-Ping Huo; Cui Liu; Bei-Bei Jin; Feng-Xia Duan; Sheng-Hui Mei; Xin-Gang Li; Zhi-Gang Zhao
Journal:  Exp Ther Med       Date:  2017-10-30       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.